{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:40:57Z","timestamp":1793090457725,"version":"4.5.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T00:00:00Z","timestamp":1294876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0016187","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T21:38:55Z","timestamp":1294954735000},"page":"e16187","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":123,"title":["Creatine Transporter (CrT; Slc6a8) Knockout Mice as a Model of Human CrT Deficiency"],"prefix":"10.1371","volume":"6","author":[{"given":"Matthew R.","family":"Skelton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tori L.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon L.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ton J.","family":"deGrauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles V.","family":"Vorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","article-title":"Creatine and creatinine metabolism.","volume":"80","author":"M Wyss","year":"2000","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0888-7543(95)80155-F","article-title":"Assignment of the creatine transporter gene (SLC6A8) to human chromosome Xq28 telomeric to G6PD.","volume":"25","author":"P Gregor","year":"1995","journal-title":"Genomics"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ana.79","article-title":"Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?","volume":"49","author":"KM Cecil","year":"2001","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1055\/s-2002-36743","article-title":"Congenital creatine transporter deficiency.","volume":"33","author":"TJ DeGrauw","year":"2002","journal-title":"Neuropediatrics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s10545-006-0123-4","article-title":"X-linked creatine transporter defect: a report on two unrelated boys with a severe clinical phenotype.","volume":"29","author":"IA Anselm","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1023\/A:1022487218904","article-title":"The clinical syndrome of creatine transporter deficiency.","volume":"244","author":"TJ DeGrauw","year":"2003","journal-title":"Mol Cell Biochem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1528-1167.2007.01148.x","article-title":"Severe epilepsy in X-linked creatine transporter defect (CRTR-D).","volume":"48","author":"MM Mancardi","year":"2007","journal-title":"Epilepsia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s10545-006-0212-4","article-title":"X-Linked creatine transporter deficiency in two patients with severe mental retardation and autism.","volume":"29","author":"P Poo-Arguelles","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1086\/320595","article-title":"X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome.","volume":"68","author":"GS Salomons","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1024405821638","article-title":"X-linked creatine transporter defect: an overview.","volume":"26","author":"GS Salomons","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"ref11","article-title":"Creatine transporter deficiency in two adult patients with static encephalopathy.","author":"A Sempere","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10545-006-0271-6","article-title":"Overexpression of wild-type creatine transporter (SLC6A8) restores creatine uptake in primary SLC6A8-deficient fibroblasts.","volume":"29","author":"EH Rosenberg","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s10545-008-0902-1","article-title":"Arginine supplementation in four patients with X-linked creatine transporter defect.","volume":"31","author":"C Fons","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/01.wnl.0000239153.39710.81","article-title":"High frequency of creatine deficiency syndromes in patients with unexplained mental retardation.","volume":"67","author":"L Lion-Francois","year":"2006","journal-title":"Neurology"},{"key":"ref15","article-title":"The screening of SLC6A8 deficiency among Estonian families with X-linked mental retardation.","author":"H Puusepp","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00439-006-0162-9","article-title":"X-linked creatine transporter (SLC6A8) mutations in about 1% of males with mental retardation of unknown etiology.","volume":"119","author":"AJ Clark","year":"2006","journal-title":"Hum Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-213X-5-9","article-title":"Creatine synthesis and transport during rat embryogenesis: spatiotemporal expression of AGAT, GAMT and CT1.","volume":"5","author":"O Braissant","year":"2005","journal-title":"BMC Dev Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(00)00269-2","article-title":"Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study.","volume":"86","author":"O Braissant","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4020-6486-9_4","article-title":"Expression and function of AGAT, GAMT and CT1 in the mammalian brain.","volume":"46","author":"O Braissant","year":"2007","journal-title":"Subcell Biochem"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-1-4020-6486-9_5","article-title":"A novel relationship between creatine transport at the blood-brain and blood-retinal barriers, creatine biosynthesis, and its use for brain and retinal energy homeostasis.","volume":"46","author":"M Tachikawa","year":"2007","journal-title":"Subcell Biochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neuroscience.2009.06.065","article-title":"Immunohistochemical localisation of the creatine transporter in the rat brain.","volume":"163","author":"CS Mak","year":"2009","journal-title":"Neuroscience"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mrdd.20084","article-title":"Applications of gene targeting technology to mental retardation and developmental disability research.","volume":"11","author":"AF Pimenta","year":"2005","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5080","DOI":"10.1093\/nar\/23.24.5080","article-title":"A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.","volume":"23","author":"F Schwenk","year":"1995","journal-title":"Nucleic Acids Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user's guide.","volume":"10","author":"SP Brooks","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(03)02839-7","article-title":"Protein tyrosine phosphatase alpha (PTP alpha) knockout mice show deficits in Morris water maze learning, decreased locomotor activity, and decreases in anxiety.","volume":"984","author":"MR Skelton","year":"2003","journal-title":"Brain Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1601-183X.2006.00209.x","article-title":"Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice.","volume":"5","author":"LA Ehrman","year":"2006","journal-title":"Genes Brain Behav"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.neuroscience.2009.09.059","article-title":"Mouse plasmacytoma-expressed transcript 1 knock out induced 5-HT disruption results in a lack of cognitive deficits and an anxiety phenotype complicated by hypoactivity and defensiveness.","volume":"164","author":"TL Schaefer","year":"2009","journal-title":"Neuroscience"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: procedures for assessing spatial and related forms of learning and memory.","volume":"1","author":"CV Vorhees","year":"2006","journal-title":"Nature Protocols"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"8853","DOI":"10.1523\/JNEUROSCI.20-23-08853.2000","article-title":"Impaired recognition memory in rats after damage to the hippocampus.","volume":"20","author":"RE Clark","year":"2000","journal-title":"J Neurosci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1750-3639.2007.00096.x","article-title":"Mouse behavioral assays relevant to the symptoms of autism.","volume":"17","author":"JN Crawley","year":"2007","journal-title":"Brain Pathol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.neubiorev.2009.02.001","article-title":"Top-down modulation of prepulse inhibition of the startle reflex in humans and rats.","volume":"33","author":"L Li","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1126\/science.1186909","article-title":"Induction of fear extinction with hippocampal-infralimbic BDNF.","volume":"328","author":"J Peters","year":"2010","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ntt.2010.01.006","article-title":"Effect of a neurotoxic dose regimen of (+)-methamphetamine on behavior, plasma corticosterone, and brain monoamines in adult C57BL\/6 mice.","volume":"32","author":"CE Grace","year":"2010","journal-title":"Neurotoxicol Teratol"},{"key":"ref34","article-title":"AGAT, GAMT and SLC6A8 distribution in the central nervous system, in relation to creatine deficiency syndromes: A review.","author":"O Braissant","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/B:MCBI.0000038213.15646.4a","article-title":"Presence of normal creatine in the muscle of a patient with a mutation in the creatine transporter: a case study.","volume":"262","author":"GJ Pyne-Geithman","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0378-1119(95)00104-E","article-title":"Cloning and sequencing of a cDNA encoding a novel member of the human brain GABA\/noradrenaline neurotransmitter transporter family.","volume":"159","author":"LF Barnwell","year":"1995","journal-title":"Gene"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.gene.2008.04.003","article-title":"Identification, characterization and cloning of SLC6A8C, a novel splice variant of the creatine transporter gene.","volume":"418","author":"C Martinez-Munoz","year":"2008","journal-title":"Gene"},{"key":"ref38","first-page":"127","article-title":"Ontogeny regulates creatine metabolism in rat small and large intestine.","volume":"60","author":"P Garcia-Miranda","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"C1015","DOI":"10.1152\/ajpcell.00137.2005","article-title":"Creatine transporter localization in developing and adult retina: importance of creatine to retinal function.","volume":"289","author":"ML Acosta","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.brainresbull.2009.09.007","article-title":"Brain creatine kinase activity is increased by chronic administration of paroxetine.","volume":"80","author":"PM Santos","year":"2009","journal-title":"Brain Res Bull"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.brainresbull.2009.09.002","article-title":"Effects of olanzapine, fluoxetine and olanzapine\/fluoxetine on creatine kinase activity in rat brain.","volume":"80","author":"FR Agostinho","year":"2009","journal-title":"Brain Res Bull"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.mcn.2007.08.004","article-title":"Serotonin stimulates mitochondrial transport in hippocampal neurons.","volume":"36","author":"S Chen","year":"2007","journal-title":"Mol Cell Neurosci"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1124\/jpet.109.159947","article-title":"5-hydroxytryptamine receptor stimulation of mitochondrial biogenesis.","volume":"332","author":"KA Rasbach","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0306-4522(02)00484-0","article-title":"Effects of genetic depletion of monoamines on somatosensory corical development.","volume":"115","author":"C Alvarez","year":"2002","journal-title":"Neuroscience"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/WNR.0b013e3282fd6e88","article-title":"Novel monoamine oxidase A knock out mice with human-like spontaneous mutation.","volume":"19","author":"AL Scott","year":"2010","journal-title":"Neuroreport"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0016187","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:02:34Z","timestamp":1589007754000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0016187"}},"subtitle":[],"editor":[{"given":"Efthimios M. C.","family":"Skoulakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0016187","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,13]]}}}